Nathan Smith

LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies

Changyoun Kim, Alexandria Beilina, Nathan Smith et al. · Science Translational Medicine · 2020 · 77 citations · Full text

Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial

Cory A. Perugino, Zachary S. Wallace, Debra Zack et al. · The Lancet Rheumatology · 2023 · 53 citations

Pilot Trial, Autoimmune Disease, Igg4-related Disease +11

Protein target highlights in <scp>CASP15</scp> : Analysis of models by structure providers

Leila T. Alexander, Janani Durairaj, Andriy Kryshtafovych et al. · Proteins Structure Function and Bioinformatics · 2023 · 32 citations · Full text

Intra-wound vancomycin and tobramycin powder for infection prophylaxis in orthopaedic trauma surgery: Economically justifiable?

Gregory J. Kirchner, Nathan Smith, Matthew R. Garner · Injury · 2021 · 18 citations

Infection Prophylaxis, Antibiotics, Tobramycin Powder +13

Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity

Belén Fernández, Vinita G. Chittoor-Vinod, Jillian H. Kluss et al. · Journal of Parkinson s Disease · 2022 · 17 citations · Full text